| Oct 15 |
Do Its Financials Have Any Role To Play In Driving Hims & Hers Health, Inc.'s (NYSE:HIMS) Stock Up Recently?
|
| Oct 14 |
Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug
|
| Oct 14 |
Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024
|
| Oct 14 |
Hims & Hers surges as FDA mulls over compounded drugs limit
|
| Oct 14 |
Hims & Hers up 10% as FDA reconsiders taking Lilly weight loss drug off shortage list
|
| Oct 11 |
DEA set to extend COVID-era telehealth prescribing rules: Politico
|
| Oct 10 |
WeightWatchers stock rallies 170%! But new compounded GLP-1 drug is 'not a sustainable long-term business model.'
|
| Oct 8 |
FDA Sparks Controversy With Sudden Removal Of Eli Lilly's Weight Loss Drug From Shortage List
|
| Oct 7 |
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
|
| Oct 5 |
Hims & Hers to replace Vector Group in the S&P SmallCap 600
|
